2. Kasapkara CS, Olgac A, Kilic M, Keldermans L, Matthijs G, Jaeken J. 2021; MAN1B1-CDG: novel patients and novel variant. J Pediatr Endocrinol Metab. 34:1207–9. DOI:
10.1515/jpem-2021-0038. PMID:
34162022.
4. Sakhi S, Cholet S, Wehbi S, Isidor B, Cogne B, Vuillaumier-Barrot S, et al. 2021; MAN1B1-CDG: three new individuals and associated biochemical profiles. Mol Genet Metab Rep. 28:100775. DOI:
10.1016/j.ymgmr.2021.100775. PMID:
34141584. PMCID:
PMC8182421.
5. Gustafsson OJ, Briggs MT, Condina MR, Winderbaum LJ, Pelzing M, McColl SR, et al. 2015; MALDI imaging mass spectrometry of N-linked glycans on formalin-fixed paraffin-embedded murine kidney. Anal Bioanal Chem. 407:2127–39. DOI:
10.1007/s00216-014-8293-7. PMID:
25434632. PMCID:
PMC4357650.
6. Gupta S, Fahiminiya S, Wang T, Dempsey Nunez L, Rosenblatt DS, Gibson WT. 2016; Somatic overgrowth associated with homozygous mutations in both MAN1B1 and SEC23A. Cold Spring Harb Mol Case Stud. 2:a000737. DOI:
10.1101/mcs.a000737. PMID:
27148587. PMCID:
PMC4853519.
7. Sun AH, Collette JR, Sifers RN. 2020; The cytoplasmic tail of human mannosidase Man1b1 contributes to catalysis-independent quality control of misfolded alpha1-antitrypsin. Proc Natl Acad Sci U S A. 117:24825–36. DOI:
10.1073/pnas.1919013117. PMID:
32958677. PMCID:
PMC7547240.
8. Rafiq MA, Kuss AW, Puettmann L, Noor A, Ramiah A, Ali G, et al. 2011; Mutations in the alpha 1,2-mannosidase gene, MAN1B1, cause autosomal-recessive intellectual disability. Am J Hum Genet. 89:176–82. DOI:
10.1016/j.ajhg.2011.06.006. PMID:
21763484. PMCID:
PMC3135808.
9. Hoffjan S, Epplen JT, Reis A, Abou Jamra R. 2015; MAN1B1 mutation leads to a recognizable phenotype: a case report and future prospects. Mol Syndromol. 6:58–62. DOI:
10.1159/000371399. PMID:
26279649. PMCID:
PMC4521065.
10. Balasubramanian M, Johnson DS. DDD Study. 2019; MAN1B-CDG: Novel variants with a distinct phenotype and review of literature. Eur J Med Genet. 62:109–14. DOI:
10.1016/j.ejmg.2018.06.011. PMID:
29908352.